{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:58:49Z","timestamp":1789545529999,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374272"],"award-info":[{"award-number":["82374272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome is a rare autoinflammatory disease. Paradoxical reactions and immune deviation following biologic therapy are occasionally observed in clinical practice; however, to our knowledge, no previous cases of paradoxical skin rash accompanied by Hyperimmunoglobulinemia E have been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 35-year-old male with SAPHO syndrome experienced significant exacerbation of palmoplantar pustulosis and a sharp increase in immunoglobulin E(IgE) levels following treatment with secukinumab and infliximab. After one month of upadacitinib therapy, the patient showed marked improvement in cutaneous lesions and bone pain, along with significant normalization of inflammatory markers and a pronounced reduction in IgE levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests that upadacitinib may be a valuable therapeutic option for patients with refractory SAPHO syndrome, particularly those presenting with paradoxical reactions or hypersensitivity. The unique mechanism of action of Janus kinase (JAK) inhibitors may offer superior efficacy in such cases, though further clinical validation and mechanistic studies are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1728245","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:45:18Z","timestamp":1770273918000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Upadacitinib for SAPHO syndrome with biologics-induced paradoxical manifestation and Hyperimmunoglobulinemia E"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuxi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Critical Rheumatology and Immunology, Clinical Immunology Centre, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Weifang People\u2019s Hospital","place":["Weifang, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Rheumatology and Immunology, Clinical Immunology Centre, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of traditional Chinese medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tianjin Institute of Integrative Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Rheumatology and Immunology, Clinical Immunology Centre, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.05.006","article-title":"The SAPHO syndrome","volume":"42","author":"Minhchau Thi","year":"2012","journal-title":"Semin Arthritis Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.97394","article-title":"SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review","volume":"38","author":"Przepiera-B\u0119dzak","year":"2021","journal-title":"Postepy Dermatol Alergol Dec"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003688","article-title":"Treatment and monitoring of SAPHO syndrome: a systematic review","volume":"9","author":"Li","year":"2023","journal-title":"RMD Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of upadacitinib and adalimumab for psoriatic arthritis","volume":"384","author":"Iain","year":"2021","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1782049","article-title":"A review of upadacitinib in rheumatoid arthritis","volume":"30","author":"Tanaka","year":"2020","journal-title":"Mod Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01690-7","article-title":"Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy","volume":"72","author":"Criado","year":"2023","journal-title":"Inflammation Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/all.15449","article-title":"Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity","volume":"77","author":"Oscar","year":"2022","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Retrospective analysis of the clinical response of palmoplantar pustulosis after dental infection control and dental metal removal","volume":"44","author":"Michiyoshi","year":"2017","journal-title":"J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Risk of paradoxical eczema in patients receiving biologics for psoriasis","volume":"160","author":"Ali","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B10","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"B11","article-title":"Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome","volume":"23","author":"Kotilainen","year":"1996","journal-title":"J Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2024.05.015","article-title":"Paradoxical psoriasis: an updated review of clinical features, pathogenesis, and treatment options","volume":"144","author":"Carlo Alberto","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.05.016","article-title":"IL-23\/Th17 targeted therapies in SAPHO syndrome. A case series","volume":"84","author":"Daniel","year":"2017","journal-title":"Joint Bone Spine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.04.027","article-title":"Single-cell analysis implicates T(H)17-to-T(H)2 cell plasticity in the pathogenesis of palmoplantar pustulosis","volume":"150","author":"Daniel","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Daniella","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41927-018-0031-x","article-title":"In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)","volume":"2","author":"Parmentier","year":"2018","journal-title":"BMC Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1068260","article-title":"JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review","volume":"13","author":"I-Hsin","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2021.10.004","article-title":"Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors","volume":"71","author":"Chisa","year":"2021","journal-title":"Allergol Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020178","article-title":"Comparative efficacy and safety of JAK inhibitors in the management of rheumatoid arthritis: A network meta-analysis","volume":"18","author":"Almoallim","year":"2025","journal-title":"Pharm (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei221","article-title":"In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations","volume":"45","author":"Massara","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq122","article-title":"Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood","volume":"49","author":"Eleftheriou","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2606-y","article-title":"The lobster sign in SAPHO syndrome: unusually extensive osteitis of the anterior chest wall partially responsive to infliximab","volume":"34","author":"Branimir","year":"2012","journal-title":"Rheumatol Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520949100","article-title":"Successful treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis and paradoxical skin lesions by Tripterygium wilfordii hook f: a case report","volume":"48","author":"Xinlu","year":"2020","journal-title":"J Int Med Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4083-5","article-title":"Paradoxical skin lesions induced by anti-TNF-\u03b1 agents in SAPHO syndrome","volume":"38","author":"Chen","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1628279","article-title":"Case Report: Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and palmoplantar pustulosis with ustekinumab","volume":"16","author":"Luxia","year":"2025","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S454057","article-title":"Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome and paradoxical psoriasis with secukinumab: A case report","volume":"17","author":"Danyang","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9076852","article-title":"Risankizumab efficacy in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) remission: A case report on rheumatologic and dermatologic disease manifestations with literature review","volume":"2024","author":"Mario","year":"2024","journal-title":"Case Rep Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S510006","article-title":"Awareness of the risk of paradoxical psoriasis in patients with SAPHO syndrome undergoing treatment with secukinumab: A case series","volume":"18","author":"Cheng","year":"2025","journal-title":"J Inflammation Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16071","article-title":"Successful treatment of SAPHO syndrome with apremilast","volume":"179","author":"S","year":"2017","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.70305","article-title":"Case report: successful treatment of secukinumab-induced SAPHO syndrome with tofacitinib","volume":"28","author":"Man","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12525","article-title":"Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis","volume":"18","author":"Fujita","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518806105","article-title":"Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report","volume":"46","author":"Sun","year":"2018","journal-title":"J Int Med Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1476793","article-title":"Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients","volume":"11","author":"Na","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B34","year":"2025"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14774","article-title":"Novel JAK-1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report","volume":"26","author":"Mingwei","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e11149","DOI":"10.1097\/MD.0000000000011149","article-title":"Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib","volume":"97","author":"Yang","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i19.4527","article-title":"Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report","volume":"8","author":"Chen","year":"2020","journal-title":"World J Clin Cases"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217250","article-title":"Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation","volume":"79","author":"Yueting","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.3095","article-title":"Tofacitinib for the treatment of nail lesions and palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome","volume":"157","author":"Chen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000000441","article-title":"Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome","volume":"132","author":"Shuang","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911922","article-title":"SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: A case report","volume":"13","author":"Fangfang","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14628","article-title":"SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib","volume":"26","author":"Chen","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14693","article-title":"SAPHO syndrome complicated with relapsing polychondritis: A case report","volume":"26","author":"Fengjiao","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S392909","article-title":"Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with henoch-sch\u00f6nlein purpura: A case report","volume":"16","author":"Ruoyi","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkac084","article-title":"Successful treatment of hip involvement in SAPHO syndrome with baricitinib","volume":"6","author":"Wuriliga","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S446468","article-title":"Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with baricitinib, a janus kinase inhibitor","volume":"17","author":"Jianqiu","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105587","article-title":"Efficacy of baricitinib in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A case series","volume":"90","author":"Shengyan","year":"2023","journal-title":"Joint Bone Spine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1728245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:57:33Z","timestamp":1771927053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1728245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2026.1728245"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1728245","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1728245"}}